Epigenetics-targeted drugs: current paradigms and future challenges

W Dai, X Qiao, Y Fang, R Guo, P Bai, S Liu… - … and Targeted Therapy, 2024 - nature.com
Epigenetics governs a chromatin state regulatory system through five key mechanisms: DNA
modification, histone modification, RNA modification, chromatin remodeling, and non-coding …

Dynamic scRNA-seq of live human pancreatic slices reveals functional endocrine cell neogenesis through an intermediate ducto-acinar stage

M Doke, S Álvarez-Cubela, D Klein, I Altilio, J Schulz… - Cell Metabolism, 2023 - cell.com
Human pancreatic plasticity is implied from multiple single-cell RNA sequencing (scRNA-
seq) studies. However, these have been invariably based on static datasets from which fate …

Diabetes Mellitus across the Arabo‐Islamic World: A Revolution

M Fleifel, B Fleifel, A El Alam - International Journal of …, 2023 - Wiley Online Library
Background. Mankind continues to suffer from the ever‐growing diabetes epidemic and the
rapid rise of type 2 diabetes mellitus (T2DM). This metabolic disease has been studied since …

EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors

K Al-Hasani, SN Marikar, H Kaipananickal… - … and Targeted Therapy, 2024 - nature.com
Abstract β-cells are a type of endocrine cell found in pancreatic islets that synthesize, store
and release insulin. In type 1 diabetes (T1D), T-cells of the immune system selectively …

Multi-regulator of EZH2-PPARs therapeutic targets: a hallmark for prospective restoration of pancreatic insulin production and cancer dysregulation

CB Olowosoke, O Gbemisola, AA Alaba… - Applied Biochemistry …, 2023 - Springer
The unexpected rise in cancer and diabetes statistics has been a significant global threat,
inciting ongoing research into various biomarkers that can act as innovative therapeutic …

Pharmacological inhibition of human EZH2 can influence a regenerative β-like cell capacity with in vitro insulin release in pancreatic ductal cells

S Naina Marikar, K Al-Hasani, I Khurana… - Clinical …, 2023 - Springer
Background Therapeutic replacement of pancreatic endocrine β-cells is key to improving
hyperglycaemia caused by insulin-dependent diabetes. Whilst the pool of ductal …

Droplet Microfluidics Powered Hydrogel Microparticles for Stem Cell‐Mediated Biomedical Applications

F Zheng, R Tian, H Lu, X Liang, M Shafiq, S Uchida… - Small, 2024 - Wiley Online Library
Stem cell‐related therapeutic technologies have garnered significant attention of the
research community for their multi‐faceted applications. To promote the therapeutic effects …

[HTML][HTML] Investigation of polymorphism role in protein structure and function for selected cancer and diabetes disease; a rationale to selection of targets for insilico drug …

CB Olowosoke, TA Ibisanmi, CJ Eze… - Informatics in Medicine …, 2023 - Elsevier
Objectives Cancer and diabetes are two diseases known to bypass socio-demographic
segregation, hence the increased focus on their molecular mechanism for therapeutic …

z-independent and -dependent Improvements With EPA Supplementation on the Early Type 1 Diabetes Phenotype of NOD Mice

RJ Fenske, HN Wienkes, DC Peter… - Journal of the …, 2024 - academic.oup.com
Abstract Prostaglandin E2 (PGE2) is a key mediator of inflammation and is derived from the
omega-6 polyunsaturated fatty acid, arachidonic acid (AA). In the β-cell, the PGE2 receptor …

[PDF][PDF] Informatics in Medicine Unlocked

CB Olowosoke, TA Ibisanmi, CJ Eze, AA Shofunde… - researchgate.net
Objectives: Cancer and diabetes are two diseases known to bypass socio-demographic
segregation, hence the increased focus on their molecular mechanism for therapeutic …